Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSD | P07339 | 1/20 | 0.35 |
| ▸ | NPC1 | O15118 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.32 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.32 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.32 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.32 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.32 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.32 |
| ▸ | MTNR1A | P48039 | 4/20 | 0.32 |
| ▸ | MTNR1B | P49286 | 3/20 | 0.32 |
| ▸ | PAOX | Q6QHF9 | 3/20 | 0.31 |
| ▸ | KDM5C | P41229 | 1/20 | 0.31 |
| ▸ | PHF8 | Q9UPP1 | 1/20 | 0.31 |
| ▸ | KDM2A | Q9Y2K7 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5708350 | 1.00 | CTSD (0.35) | CTSDNPC1KDM4EHIF1AMAPK1 | |
| SCHEMBL13411703 | 0.78 | KDM4E (0.43) | NPC1KDM4EHIF1AMAPK1CYP2C19 | |
| SCHEMBL28596491 | 0.78 | SLC22A6 (0.43) | CTSDKDM4EHIF1ACYP1A2CYP3A4 | |
| SCHEMBL5708314 | 0.77 | SLC22A6 (0.52) | NPC1KDM4EHIF1AMAPK1MTNR1A | |
| SCHEMBL5708313 | 0.77 | SLC22A6 (0.52) | NPC1KDM4EHIF1AMAPK1MTNR1A | |
| SCHEMBL5708306 | 0.75 | MEN1 (0.41) | KDM4E | |
| SCHEMBL5708307 | 0.75 | MEN1 (0.41) | KDM4E | |
| SCHEMBL5708319 | 0.75 | FAAH (0.49) | CTSDMAPK1CYP1A2CYP3A4CYP2C19 | |
| SCHEMBL5708321 | 0.75 | FAAH (0.49) | CTSDMAPK1CYP1A2CYP3A4CYP2C19 | |
| SCHEMBL24254458 | 0.74 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1008590-B1 | Process for preparing optically active oxazolidinone derivatives | TAKASAGO PERFUMERY CO LTD (JP) | 2006-10-11 | — | — | EP | disclosed |
| US-6403804-B1 | ALLOWING HYDRAZINE TO REACT ON OPTICALLY ACTIVE ACID ESTER HAVING HYDROXYL GROUP AT 3-POSITION TO GIVE OPTICALLY ACTIVE HYDRAZIDE HAVING HYDROXYL GROUP AT 3-POSITION, SUBJECTING OPTICALLY ACTIVE HYDRAZIDE TO CURTIUS REARRANGEMENT | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2002-06-11 | — | — | US | disclosed |
| EP-1008590-A1 | Process for preparing optically active oxazolidinone derivative | Takasago International Corporation (JP) | 2000-06-14 | — | — | EP | disclosed |